Stipple Bio
Last verified 2026-04-29. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $109.0Mattributed |
|---|---|
| Latest round | series-a, $100.0M, 2026-04-01attributed |
| Founded | unknown |
| Headquarters | Cambridge, United States |
| Industry | bio |
| Stage | series-a |
| Website | stipple.bio |
Stipple Bio designs tumor-specific antibody therapies using an epitope-level 'pointillist' discovery approach. It serves oncology patients with cancers driven by surface targets that conventional antibody discovery misses. The stippling method finds subtle tumor-vs-healthy epitope differences instead of optimizing the most-abundant target.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | series-a | $100.0M | undisclosed |
Detected tech stack
Nginx, WordPress 7.0, Astra 4.12.3, Google Hosted Libraries, jQuery Migrate 3.4.1, Elementor 4.0.9, Python, PHP, MySQL, jquery 2.1.1
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $100.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Total raised $109.0M | attributed | crunchbase named as publisher. No document URL on file. |
| Company existence | self-reported | stipple.bio, read 2026-04-29 |
| Description | self-reported | stipple.bio, read 2026-04-29 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.